Ocuphire Pharma, Inc.·4

May 23, 4:58 PM ET

Sooch Mina 4

4 · Ocuphire Pharma, Inc. · Filed May 23, 2022

Insider Transaction Report

Form 4
Period: 2022-05-19
Sooch Mina
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2022-05-19$2.07/sh+12,500$25,879412,522 total
  • Purchase

    Common Stock

    2022-05-20$2.02/sh+12,500$25,300425,022 total
Footnotes (2)
  • [F1]The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $2.045 to $2.10. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
  • [F2]The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $2.015 to $2.025. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4